Compare CVS Health Corp (CVS) vs Manchester United PLC (MANU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Manchester United PLC — how do they compare? CVS Health Corp trades at $104.26 (market cap $135.48B), while Manchester United PLC trades at $22.05 (market cap $3.80B). The key difference: CVS Health Corp is far larger — about 35.7× Manchester United PLC's market cap, and CVS Health Corp pays the higher dividend (2.51%). Which is the better fit depends on your goals.
| CVS | MANU | |
|---|---|---|
Market Cap | $135.48B | $3.80B |
Sector | Health | Media |
52-Week High | $106.18 | $23.53 |
52-Week Low | $58.75 | $15.10 |
Enterprise Value | $202.02B | $4.72B |
Dividend Yield | 2.51% | 1.26% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $105.9, up 1.68% recently, with a bullish technical signal and strong analyst support (84.6% buy ratings). The company has beaten earnings estimates for three consecutive quarters, including Q1 2026 EPS of $2.57 versus $2.18 expected. Revenue growth remains robust, reaching $402.07B in 2025, though net margins are thin at 0.72%. Recent news highlights a settlement with the FTC advancing prescription drug affordability initiatives.
The outlook is positive given earnings momentum and strategic positioning in healthcare services, but risks include regulatory pressures and margin compression. The consensus price target of $110.62 suggests modest upside from current levels, supported by dividend payments and institutional confidence.
Manchester United (MANU) trades at $22.31, up 1.23% today, with a bullish technical signal from moving averages. Recent quarterly earnings show mixed results, beating expectations in two of the last four quarters. The company reported a net loss of $33.02 million for 2025, though revenue grew to $666.51 million. Positive developments include securing land for a new 100,000-seat stadium and Champions League qualification, which may boost future revenue.
The outlook is cautiously optimistic with 40% of analysts rating the stock a buy, but high debt levels and inconsistent profitability pose risks. Upside potential exists from stadium development and improved sporting performance, while investor sentiment is supported by institutional interest and strategic partnerships.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Manchester United PLC
Manchester United PLC operates a professional football club together with related and ancillary activities. The company manages the soccer team and all affiliated club activities of the Manchester United Football Club, which includes the media network, foundation, fan zone, news, sports features, and team merchandise. Manchester United is based in England. The company has three principal sectors from which most of the revenue is generated, including Commercial, Broadcasting, and Matchday.
Read more on MANU →
